Octagam (Immune Globulin Intravenous (human)) 5% Liquid Preparation: Market Withdrawal
Free Octagam® Recall Case Evaluation: If you or a loved one has been injured by Octagam, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.
What’s the problem?
September 25, 2010 – Effective immediately, Octapharma is initiating a market withdrawal of ALL lots of Octagam currently in the US market as a result of an increased number of reported thromboembolic events, some of which were serious. There were 9 thromboembolic events potentially associated with 7 of the lots that are being withdrawn from the market.
Octagam is indicated for treatment of primary humoral immunodeficiency (PI), such as congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome and severe combined immunodeficiencies. Customers are asked to immediately quarantine the use of affected lots.
Do I have an Octagam Injury Lawsuit?
The Defective Drug & Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Octagam recall lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.